Jörg O. Schwab - Concepedia

Author

Jörg O. Schwab

Also Known As

Edgar Zitron, J. O. Schwab, Jörg O. Schwab, JÖRG O. SCHWAB, JÖRG OTTO SCHWAB, Jörg O Schwab, Jörg O. Schwab, Jörg Otto Schwab, Jörg Schwab

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Bonn University Hospital Bonn Zimmer Biomet (Germany)Justus-Liebig-Universität Gießen

About

Jörg O. Schwab is an author at University of Bonn specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	650
2	Public Health	2	2	434
3	Health Sciences	1	1	132
4	Cell Biology	1	1	32
5	Cellular Physiology	1	1	32

Jörg O. Schwab

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Risk and Fate of Cerebral Embolism After Transfemoral Aortic Valve Implantation Alexander Ghanem, Andreas Müller, Claas Philip Nähle, Journal of the American College of Cardiology ThrombosisCerebral EmbolismEndovascular TechniqueCardiovascular DiseaseMedicine	2010	347
Cerebral Diffusion‐Weighted Magnetic Resonance Imaging: A Tool to Monitor the Thrombogenicity of Left Atrial Catheter Ablation Lars Lickfett, M. H. Hackenbroch, Thorsten Lewalter, Journal of Cardiovascular Electrophysiology	2005	203
Magnetic Resonance Imaging at 1.5-T in Patients With Implantable Cardioverter-Defibrillators Claas P. Naehle, Katharina Strach, Daniel Thomas, Journal of the American College of Cardiology Electrophysiological EvaluationHeart FailureHealth SciencesMedical ImagingDevice Therapy	2009	132
Cognitive Trajectory After Transcatheter Aortic Valve Implantation Alexander Ghanem, Justine Kocurek, Jan‐Malte Sinning, Circulation Cardiovascular Interventions	2013	99
Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T Claas P. Naehle, Jens Kreuz, Katharina Strach, American Heart Journal Cardiac PacemakersMedical ImagingCardiovascular DiseaseImplantable Cardioverters/defibrillatorsDevice Therapy	2011	87
Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy Christof Kolb, Marcio Sturmer, Peter Sick, JACC Heart Failure	2014	61
Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction René Andrié, Ulrich Becher, Ricarda Frommold, Critical Care	2012	53
Cardiac Resynchronization Therapy and Atrial Overdrive Pacing for the Treatment of Central Sleep Apnoea Lars Lüthje, Bernd Renner, Roger Kessels, European Journal of Heart Failure	2009	41
Gold‐Tip Electrodes—A New “Deep Lesion” Technology for Catheter Ablation? In Vitro Comparison of a Gold Alloy Versus Platinum–Iridium Tip Electrode Ablation Catheter Thorsten Lewalter, A. Bitzen, S. Wurtz, Journal of Cardiovascular Electrophysiology	2005	38
Usefulness of Sleep-Disordered Breathing to Predict Occurrence of Appropriate and Inappropriate Implantable-Cardioverter Defibrillator Therapy in Patients With Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death Jens Kreuz, Dirk Skowasch, Fritz Horlbeck, The American Journal of Cardiology Sleep-disordered BreathingSleepPrimary PreventionSleep-related Breathing DisorderCardiopulmonary Resuscitation	2013	36

Page 1